References
- Grama A, Aldea CO, Burac L, Delean D, Bulata B, Sirbe C, et al. Etiology and outcome of acute liver failure in children-the experience of a single tertiary care hospital from Romania. Children (Basel) 2020;7:282.
- Maheshwari A, Bajpai M, Patidar GK. Effects of therapeutic plasma exchange on liver function test and coagulation parameters in acute liver failure patients. Hematol Transfus Cell Ther 2020;42:125-8. https://doi.org/10.1016/j.htct.2019.05.003
- European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. Wendon J; Panel membersCordoba J, Dhawan A, Larsen FS, Manns M, Samuel D, Simpson KJ, et al.; EASL Governing Board representative, Bernardi M. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol 2017;66:1047-81. https://doi.org/10.1016/j.jhep.2016.12.003
- Bernal W, Wendon J. Acute liver failure. N Engl J Med 2013;369:2525-34. https://doi.org/10.1056/NEJMra1208937
- Larsen FS, Schmidt LE, Bernsmeier C, Rasmussen A, Isoniemi H, Patel VC, et al. High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol 2016;64:69-78. https://doi.org/10.1016/j.jhep.2015.08.018
- Padmanabhan A, Connelly-Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, et al. Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the Writing Committee of the American Society for Apheresis: the eighth special issue. J Clin Apher 2019;34:171-354. https://doi.org/10.1002/jca.21705
- Verma N, Pai G, Hari P, Lodha R. Plasma exchange for hemolytic crisis and acute liver failure in Wilson disease. Indian J Pediatr 2014;81:498-500. https://doi.org/10.1007/s12098-013-0979-x
- Morgan SM, Zantek ND. Therapeutic plasma exchange for fulminant hepatic failure secondary to Wilson's disease. J Clin Apher 2012;27:282-6. https://doi.org/10.1002/jca.21239
- McPhail MJ, Farne H, Senvar N, Wendon JA, Bernal W. Ability of King's College criteria and model for end-stage liver disease scores to predict mortality of patients with acute liver failure: a meta-analysis. Clin Gastroenterol Hepatol 2016;14:516-25.e5; quiz e43-e5. https://doi.org/10.1016/j.cgh.2015.10.007
- Barshes NR, Lee TC, Udell IW, O'Mahoney CA, Karpen SJ, Carter BA, et al. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients. Liver Transpl 2006;12:475-80. https://doi.org/10.1002/lt.20703
- Tan EX, Wang MX, Pang J, Lee GH. Plasma exchange in patients with acute and acute-on-chronic liver failure: a systematic review. World J Gastroenterol 2020;26:219-45. https://doi.org/10.3748/wjg.v26.i2.219
- Chien MM, Chang MH, Chang KC, Lu FT, Chiu YC, Chen HL, et al. Prognostic parameters of pediatric acute liver failure and the role of plasma exchange. Pediatr Neonatol 2019;60:389-95. https://doi.org/10.1016/j.pedneo.2018.09.006
- Possamai LA, Thursz MR, Wendon JA, Antoniades CG. Modulation of monocyte/macrophage function: a therapeutic strategy in the treatment of acute liver failure. J Hepatol 2014;61:439-45. https://doi.org/10.1016/j.jhep.2014.03.031
- Alexander EC, Deep A. Therapeutic plasma exchange in children with acute liver failure (ALF): is it time for incorporation into the ALF armamentarium? Pediatr Nephrol 2022;37:1775-88. https://doi.org/10.1007/s00467-021-05289-0